David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HI
1276
DELISTED
Hillenbrand
HI
| $4.88M | 0.01% |
162,864
-36,456
| -18% | -$1.01M |
|
|
SFS
1277
DELISTED
Smart & Final Stores, Inc.
SFS
| $4.87M | 0.01% |
300,758
-1,333
| -0.4% | -$21.5K |
|
1278
PUT
Illumina
ILMN
$34B
| $4.86M | 0.01% |
30,840
-129,322
| -81% | -$19.8M |
|
1279
CALL
Norfolk Southern
NSC
$78.9B
| $4.86M | 0.01% |
58,400
-202,300
| -78% | -$15.3M |
|
1280
F5
FFIV
$21.7B
| $4.85M | 0.01% |
45,791
-95,255
| -68% | -$9.13M |
|
1281
CALL
Seagate
STX
$186B
| $4.84M | 0.01% |
140,400
+34,400
| +32% | +$1.11M |
|
1282
Gold Fields
GFI
$43.5B
| $4.83M | 0.01% |
1,227,108
+638,686
| +109% | +$2.39M |
|
|
UNTD
1283
DELISTED
UNITED ONLINE INC COM NEW
UNTD
| $4.83M | 0.01% |
418,591
+14,641
| +4% | +$164K |
|
|
DCM
1284
DELISTED
NTT DOCOMO, Inc.
DCM
| $4.83M | 0.01% |
211,967
+55,889
| +36% | +$1.25M |
|
|
PRA
1285
DELISTED
ProAssurance
PRA
| $4.82M | 0.01% |
95,341
+3,616
| +4% | +$178K |
|
1286
Insperity
NSP
$2B
| $4.82M | 0.01% |
186,348
-68,658
| -27% | -$1.62M |
|
1287
CALL
Hershey
HSY
$37.6B
| $4.82M | 0.01% |
52,300
-222,500
| -81% | -$19.9M |
|
1288
PUT
Teva Pharmaceuticals
TEVA
$44.4B
| $4.82M | 0.01% |
90,000
-88,200
| -49% | -$5.18M |
|
1289
PUT
Advance Auto Parts
AAP
$2.63B
| $4.81M | 0.01% |
30,000
-54,900
| -65% | -$8.26M |
|
|
SLCA
1290
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $4.78M | 0.01% |
210,404
-635,150
| -75% | -$11.8M |
|
1291
Norwegian Cruise Line
NCLH
$7.93B
| $4.76M | 0.01% |
86,158
-688,767
| -89% | -$33.2M |
|
|
RP
1292
DELISTED
RealPage, Inc.
RP
| $4.76M | 0.01% |
228,602
-87,495
| -28% | -$1.73M |
|
1293
PUT
Middleby
MIDD
$5.15B
| $4.75M | 0.01% |
+44,500
| New | +$4.18M |
|
|
LHCG
1294
DELISTED
LHC Group LLC
LHCG
| $4.75M | 0.01% |
133,551
+7,883
| +6% | +$290K |
|
|
CNR
1295
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $4.75M | 0.01% |
334,437
-86,830
| -21% | -$970K |
|
|
DNR
1296
DELISTED
Denbury Resources, Inc.
DNR
| $4.72M | 0.01% |
2,126,480
+1,876,960
| +752% | +$3.13M |
|
|
BEAT
1297
DELISTED
BioTelemetry, Inc.
BEAT
| $4.72M | 0.01% |
403,900
+103,548
| +34% | +$1.16M |
|
1298
PUT
Kraft Heinz
KHC
$30B
| $4.71M | 0.01% |
60,000
+20,000
| +50% | +$1.5M |
|
|
ANAC
1299
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $4.7M | 0.01% |
87,990
-70,780
| -45% | -$5.22M |
|
1300
Stellantis
STLA
$19.8B
| $4.7M | 0.01% |
+588,233
| New | +$4.25M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.